Africa: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Africa

The African market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses was estimated at $X in 2023, increasing by X% against the previous year. Overall, consumption recorded a relatively flat trend pattern. As a result, consumption reached the peak level of $X. From 2017 to 2023, the growth of the market failed to regain momentum.

Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Africa

In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses rose modestly to $X in 2023 estimated in export price. The total production indicated measured growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2021 indices. The pace of growth appeared the most rapid in 2013 with an increase of X% against the previous year. The level of production peaked at $X in 2021; however, from 2022 to 2023, production stood at a somewhat lower figure.

Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Exports in Africa

In 2023, the amount of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exported in Africa shrank notably to X tons, which is down by X% on 2022 figures. In general, exports, however, continue to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2017 when exports increased by X% against the previous year. As a result, the exports attained the peak of X tons. From 2018 to 2023, the growth of the exports of failed to regain momentum.

In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses reduced sharply to $X in 2023. Overall, exports saw a deep setback. The growth pace was the most rapid in 2017 with an increase of X% against the previous year. The level of export peaked at $X in 2014; however, from 2015 to 2023, the exports remained at a lower figure.

Exports by Country

South Africa represented the main exporter of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Africa, with the volume of exports resulting at X tons, which was near X% of total exports in 2023. It was distantly followed by Egypt (X tons), generating a X% share of total exports.

From 2012 to 2023, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Egypt (with a CAGR of X%).

In value terms, South Africa ($X) remains the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses supplier in Africa, comprising X% of total exports. The second position in the ranking was taken by Egypt ($X), with a X% share of total exports.

In South Africa, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses shrank by an average annual rate of X% over the period from 2012-2023.

Export Prices by Country

The export price in Africa stood at $X per ton in 2023, waning by X% against the previous year. Overall, the export price recorded a abrupt curtailment. The pace of growth was the most pronounced in 2020 an increase of X% against the previous year. Over the period under review, the export prices reached the maximum at $X per ton in 2014; however, from 2015 to 2023, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was South Africa ($X per ton), while Egypt totaled $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by South Africa (X%).

Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Imports in Africa

In 2023, approx. X tons of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses were imported in Africa; which is down by X% on the previous year's figure. Overall, imports recorded a abrupt downturn. The growth pace was the most rapid in 2015 with an increase of X%. The volume of import peaked at X tons in 2012; however, from 2013 to 2023, imports failed to regain momentum.

In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses rose modestly to $X in 2023. In general, imports showed a abrupt setback. The pace of growth was the most pronounced in 2018 when imports increased by X%. The level of import peaked at $X in 2012; however, from 2013 to 2023, imports remained at a lower figure.

Imports by Country

The countries with the highest levels of imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in 2023 were Algeria (X tons), Egypt (X tons), Botswana (X tons), Nigeria (X tons), Morocco (X tons) and South Africa (X tons), together accounting for X% of total import. Tunisia (X tons), Sudan (X tons), Lesotho (X tons), Tanzania (X tons) and Ghana (X tons) followed a long way behind the leaders.

From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Lesotho (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Algeria ($X) constitutes the largest market for imported non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Africa, comprising X% of total imports. The second position in the ranking was taken by Egypt ($X), with a X% share of total imports. It was followed by Botswana, with a X% share.

In Algeria, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses expanded at an average annual rate of X% over the period from 2012-2023. The remaining importing countries recorded the following average annual rates of imports growth: Egypt (X% per year) and Botswana (X% per year).

Import Prices by Country

In 2023, the import price in Africa amounted to $X per ton, picking up by X% against the previous year. Over the period from 2012 to 2023, it increased at an average annual rate of X%. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2022 to 2023, the import prices remained at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Algeria ($X per ton), while Lesotho ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Tanzania (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform